Altered endothelial anti-thrombotic properties have been observed in primary and secondary pulmonary hypertension. In the Eisenmenger syndrome, correlations of these abnormalities with the clinical status and occurrence of chronic intravascular coagulation (CIC) have not been confirmed. The purpose of this study was to investigate whether the occurrence of CIC, as determined by circulating levels of D-dimer is associated with changes in endothelial markers in Eisenmenger patients; and to identify variables that correlate with the severity of clinical presentation. Twenty-one patients were enrolled (ages, 4-52 years). Plasma levels of D-dimer, tissue plasminogen activator (t-PA), thrombomodulin, and von Willebrand factor antigen (vWF:Ag) were measured with enzyme-linked immunosorbent assay. Univariate and multivariate analyses were used to differentiate patients with stable (group 1, N= 12) from those with unstable disease (group 2, N=9). Increased t-PA (p<0.0001) and vWF:Ag
shear forces through the narrowed pulmonary arteries may potentially induce a hypercoagulable state with increased risk of thrombotic events (2) (3) (4) . Altered blood coagulation and thrombotic lesions in small pulmonary arteries have been indeed observed in patients with primary and secondary pulmonary hypertension (5, 6) .
Although biochemical abnormalities compatible with a prothrombotic pattern of the endothelium have been reported in several forms of pulmonary hypertension (7) (8) (9) (10) , few studies have reported these abnormalities in the specific context of chronically hypoxic Eisenmenger patients (11) . On the other hand, altered endothelial antithrombotic mechanisms have been proposed as a possible cause of thrombotic events suggesting the need for anticoagulant therapy in these patients, although clinical and laboratory evidence of ongoing intravascular coagulation has not been provided (7) (8) (9) (10) .
The present study was planned to analyze endothelial dysfunction in patients with chronic hypoxia and Eisenmenger syndrome by measuring the circulating levels of three endothelial markers. Possible relationships between these markers were investigated. Second, we examined whether endothelial dysfunction was associated with chronic intravascular coagulation by measuring the plasma levels of D-dimer, a split product of fibrin degradation by plasmin. Circulating levels of thrombomodulin, tissue-type plasminogen activator antigen (t-PA), and von Willebrand factor antigen (vWF:Ag) were determined because these substances have been used as markers of endothelial dysfunction (12) . We decided to analyze t-PA and vWF because they are colocalized within endothelial Weibel-Palade bodies (13) and secreted to the circulation under conditions known to cause endothelial activation/perturbation (12, 14) . Thrombomodulin was used in this study as a membrane-bound marker of the endothelium associated with protection against thrombosis (15) . Soluble thrombomodulin found in plasma represents proteolytic fragments of the membrane-bound proteoglycan. Levels are increased in disorders associated with proteolytic damage to the endothelial cell membrane (12) . Finally, we attempted to examine whether patients with an unstable clinical course could be differentiated from those with stable disease on the basis of clinical and biochemical variables.
METHODS

Patient Population
Pediatric and adult patients with Eisenmenger syndrome who were admitted to the Heart Institute, Sao Paulo, Brazil for diagnosis and treatment entered the study consecutively from February 2000 to October 2001. Only patients with mean pulmonary arterial pressure greater than 30 mmHg at rest were enrolled. All patients were under ambulatory care. After a careful clinical history and analysis of recent data including results of spiral computed tomography (CT) patients were classified as follows. Those with a stable clinical course, class II symptoms (NYHA) and no need for hospital care or admittance to emergency units during 2 years before the study were classified as group 1. Those with unstable disease with frequent episodes of severe cyanosis associated with dyspnea even at rest and therefore requiring home oxygen therapy and periods of hospital care constituted group 2. Patients (or their parents in case of children) were informed about the research purpose of data collection and gave their informed consent. The study was approved by the Scientific Committee of the Heart Institute.
Study Protocol
General data included patient age, gender group, and mean pulmonary artery pressure. Measurement of arterial oxygen saturation (Sao2, pulse oximetry) and blood collection for determination of the hematocrit and biochemical indexes were performed at the same time. Afterward, patient was asked to walk for 6 minutes and at that time Sao2 was recorded again. To minimize the effects of individual variations, the procedure was repeated on different days (two to four determinations per patient) and final results expressed as the mean value.
Blood Collection
Peripheral venous blood was collected without tourniquet in 1:10 volumes of 3.8% sodium citrate. Immediately after, blood samples were centrifuged at 3,000g for 20 minutes. Plasma was separated and stored at -80°C. Aliquots were thawed only once for use. Control plasma was obtained from 20 healthy subjects with an age range similar to that of patients.
Biochemical Determinations
Plasma levels of D-dimer, thrombomodulin, t-PA antigen, and vWF:Ag were determined by enzyme-linked immunosorbent assay (ELISA kits, Diagnostica Stago, Asnieres, France). Samples were processed in duplicate. Results were obtained by comparison with a standard curve with reagents provided by the manufacturer. Aliquots of pooled normal plasma from our laboratory were always run in parallel. Results were expressed as nanograms per milliliter for D-dimer, thrombomodulin, and t-PA and as units per deciliter for vWF:Ag.
Analysis of Data
Results are expressed as mean±+SD. All variables were tested for closeness to normal (Gaussian) distribution. To use parametric statistics in D-dimer analysis, logarithmic transformation was necessary. Differences between patients and controls were tested using the Student t test. Correlations between variables were tested by calculating the coefficient of correlation.
Differences between patient groups were tested first by univariate analysis using the Student t test and the Fischer's exact test. To eliminate the effects of between-group difference in Sao2, all other differences were tested using analysis of covariance. Finally, a multivariate (discriminant) model was adjusted to analyze the relative contribution of independent variables to the differentiation between patient groups. A significance level of 0.05 was assumed in all tests.
RESULTS
Twenty-one patients (10 female) entered the study with age range of 4 to 52 years (median, 30.7 years) and mean pulmonary arterial pressure of 61 ± 16 mmHg. The hematocrit was 59±5%. Resting Sao2 of 84±7% decreased significantly to 65±17% after a 6-minute walk (p<0.0001). Patients were using low dose aspirin and 2 were taking warfarin when they entered the study. No patients were using vasodilators, prostacyclin, or thrombolytic drugs. Twelve patients were classified as group 1 and 9 as group 2. Episodes of pulmonary arterial thrombosis with pulmonary infarction confirmed by spiral CT were present in recent clinical history in 2 patients in group 2 (Fig. 1 ). Episodes suggestive of transient brain ischemia were identified in 1 patient in group 1 and 1 patient in group 2.
Results of univariate analysis of biochemical data are depicted in Table 1 . In comparison with controls, patients had increased circulating levels of D-dimer (p=0.0201), t-PA (p<0.0001), and vWF:Ag (p=0.001) and decreased levels of thrombomodulin (p<0.0001). Individual nontransformed values of D-dimer are shown in Fig.  2 . Eight patients had D-dimer levels above the mean+2SD value of controls. Analysis of possible associations between variables showed a positive correlation of t-PA with vWF:Ag (r=0.49, p=0.0225). No other significant correlations were identified. Comparisons between patient groups using univariate analysis are shown in Table 2 . Group 2 was characterized by a high female-to-male ratio (p=0.0242). In comparison with group 1, group 2 patients had lower Sao2 levels at rest (p<0.0001) and during walk (p=0.0007). Between-group differences regarding all other variables were tested before and after adjustment for Sao2. Results showed that t-PA levels were significantly higher in group 2 in comparison with group 1 (p=0.0066). Analysis of associations between variables in separate groups showed that the significant correlation between t-PA and vWF:Ag was present only in group 2 (r=0.71, p=0.0309), not in group 1 (r=0.25, p=NS). Results of multivariate (discriminant) analysis are shown in Table 3 . Differentiation between groups was significant (p <0.0001). Standardized coefficients that represent the relative contribution of independent variables to the discriminant equation showed that Sao2 was the most important predictor in discriminating be-tween the groups, followed by t-PA. Using the discriminant model, the percentage of correctly classified cases relative to the original patient group was 100% and 90%, respectively, with and without inclusion of t-PA.
DISCUSSION
Results of the present study showed that in patients with chronic hypoxia and Eisenmenger syndrome, endothelial dysfunction as demonstrated by high circulating levels of t-PA and vWF:Ag and decreased thrombomodulin was associated with evidence of chronic intravascular coagulation. This was suggested by increased circulating levels of D-dimer. In addition, patients with a more unstable clinical course had not only lower Sao2, as it would be expected assuming that they had a more advanced disease, but also higher t-PA levels that correlated positively with vWF:Ag. Most of these patients were women and two of them had episodes of pulmonary thrombosis in their recent clinical history. In this context, we have previously observed a decrease in short-term survival in patients with Eisenmenger syndrome with high plasma levels of vWF:Ag (16) . Therefore, we speculate that a particular population of patients with Eisenmenger syndrome may exist in which a different pattern of endothelial perturbation is associated with a more worrisome clinical course and worse prognosis. Increased plasma levels of thrombomodulin have been reported in a number of disorders associated with proteolytic damage to the membrane of endothelial cells (17) (18) (19) (20) . Cacoub and associates were the first to demonstrate decreased rather than increased plasma levels of thrombomodulin in Eisenmenger syndrome (11) , thus suggesting that damage to the endothelial cell membrane is not a major event in this disorder. Rather, chronic hypoxia itself could account for decreased plasma thrombomodulin because hypoxia has been shown to reduce thrombomodulin expression by endothelial cells (21) . In our study, we observed that decreased plasma thrombomodulin in patients with Eisenmenger syndrome was associated with high circulating levels of D-dimer and episodes of pulmonary arterial thrombosis, therefore confirming the occurrence of intravascular coagulation. The association of decreased thrombomodulin expression with hypoxia has been shown to be a strong stimulus for fibrin deposition in lungs (22) .
We assessed plasma t-PA antigen levels as a marker of endothelial dysfunction as previously reported (12) . Measurements of t-PA activity and other components of the fibrinolytic system were not performed in this study because altered fibrinolysis has been already demonstrated in primary and secondary pulmonary hypertension (23, 24) . In our patients, we observed a significant (almost threefold) increase in plasma t-PA. This is an interesting observation because increased circulating levels of t-PA have not been reported in studies involving patients with Eisenmenger syndrome (7, 9, 23) . This discrepancy could be explained in part by differences in patient populations such as the number of subjects involved, female-to-male ratio, and severity of the disease. We have observed that t-PA levels were slightly (but significantly) higher in patients with unstable clinical course compared with those with stable disease. Moreover, t-PA and vWF:Ag correlated well in those patients. Because both proteins are colocalized within endothelial cells (13) , we speculate that a number of stimuli acting as endothelial activators in severe forms of the disease could influence plasma levels of both factors in a similar way. A comparable increase in circulating levels of t-PA has been observed in patients with primary pulmonary hypertension, with improvement following continuous prostacyclin infusion (25) . Importantly, heightened circulating t-PA antigen may be associated with impaired rather than enhanced fibrinolytic activity (26) and should not be interpreted as a protective mechanism. The possible role of t-PA in vascular remodeling that occurs in pulmonary hypertension, in particular in Eisenmenger syndrome is a matter of speculation at present. It is not known whether circulating t-PA correlates with the amount and/or activity of the enzyme present in the vascular wall. Although previous studies have suggested the role of urokinase-type plasminogen activator in vascular remodeling in experimental atherosclerosis (27, 28) , the role played by t-PA is not clear. In vitro, t-PA has been shown to be involved in capillary-like tube formation (29-31), suggesting its involvement in angiogenesis. Interestingly, capillary-like lesions have been described in severe forms of primary and secondary pulmonary hypertension, indicating a localized process of angiogenesis in lungs (32) . The possible implication of t-PA in the development of such lesions remains to be investigated. CONCLUSION Our findings showed that endothelial dysfunction in chronically hypoxic patients with Eisenmenger syndrome is associated with evidence of ongoing intravascular coagulation as suggested by high circulating levels of D-dimer and occurrence of ischemic and thrombotic events. Furthermore, differences in clinical presentation, gender distribution, and t-PA levels between patient groups with similar age range suggest that a sub-sample of subjects may exist that approaches primary pulmonary hypertension in terms of severity. Further studies are necessary, involving a larger patient population and a great number of clinical and laboratory variables to ascertain whether such a patient population actually exists.
